Another member of the class IIa HDACs, HDAC9, interacted with transcriptional suppressors and oncogenic proteins, modulating anti-tumor immunity by controlling CD8+ dendritic cells and T cell infiltration [66]. The gene discussed is HDAC9; the disease is neoplasm.